BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 6267345)

  • 1. Increased sensitivity of murine leukemia virus-infected tumor cells to lymphocyte-mediated cytotoxicity.
    Kasai M; Yamaguchi H; Hosokawa M; Mizushima Y; Kobayashi H
    J Natl Cancer Inst; 1981 Aug; 67(2):417-22. PubMed ID: 6267345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Correlation between intracellular cyclic AMP level and cytotoxic sensitivity to anti-tumor-associated antigen antibody in rat fibrosarcoma cells].
    Saito T
    Hokkaido Igaku Zasshi; 1988 Nov; 63(6):882-8. PubMed ID: 2854817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunity to virus-free syngeneic tumor cell transplantation in the BALB/c mouse after immunization with homologous tumor cells infected with type C virus.
    Al-Ghazzouli IK; Donahoe RM; Huang KY; Sass B; Peters RL; Kelloff GJ
    J Immunol; 1976 Dec; 117(6):2239-48. PubMed ID: 186539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary in vitro generation of cytolytic T-lymphocytes (CTL's) in the murine sarcoma virus system. Virus-specific CTL induction across the H-2 barrier.
    Collavo D; Parenti A; Biasi G; Chieco-Bianchi L; Colombatti A
    J Natl Cancer Inst; 1978 Sep; 61(3):885-90. PubMed ID: 80457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor sponge implantation: an in vivo method for studying syngeneic, primary antitumor lymphocyte responses.
    Vallera DA; Mentzer SJ; Maizel SE
    Cancer Res; 1982 Feb; 42(2):397-404. PubMed ID: 7055792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppression by spleen cells from Moloney leukemia. III. Evidence for a suppressor cell that is not the leukemic, virus-producing cell.
    Cerny J; Grinwich KD; Stiller RA
    J Immunol; 1977 Sep; 119(3):1097-101. PubMed ID: 330747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of immunosuppressor cells in rats immunized with solubilized tumor-associated antigens prepared from a methylcholanthrene-induced fibrosarcoma.
    Minami A; Kasai M; Mizushima Y; Takeichi N; Hosokawa M; Kobayashi H
    Cancer Res; 1980 Jul; 40(7):2129-34. PubMed ID: 6446378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T lymphocyte tolerance and early appearance of virus-induced cell surface antigens in Moloney-murine leukemia virus neonatally injected mice.
    Collavo D; Zanovello P; Biasi G; Chieco-Bianchi L
    J Immunol; 1981 Jan; 126(1):187-93. PubMed ID: 6969741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Nocardia rubra cell wall skeleton on T-cell-mediated cytotoxicity in mice bearing syngeneic sarcoma.
    Kawase I; Uemiya M; Yoshimoto T; Ogura T; Hirao F; Yamamura Y
    Cancer Res; 1981 Feb; 41(2):660-6. PubMed ID: 6969630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Enhancement of T cell-mediated immune responses in KMT-17-bearing rats by treatment with bleomycin].
    Xu ZY
    Hokkaido Igaku Zasshi; 1987 Mar; 62(2):279-88. PubMed ID: 2440789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Requirements for T cells in alloantigen-induced generation of non-T cell-mediated cytotoxicity against syngeneic mouse sarcoma cells.
    Paciucci PA; Macphail S; Bach FH; Zarling JM
    J Immunol; 1980 Jul; 125(1):36-9. PubMed ID: 6155401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow-microfluorometric monitoring of oligoclonal CD8+ T cell responses to an immunodominant Moloney leukemia virus-encoded epitope in vivo.
    Brawand P; Biasi G; Horvath C; Cerottini JC; MacDonald HR
    J Immunol; 1998 Feb; 160(4):1659-65. PubMed ID: 9469422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topographical distribution and association of tumor--associated antigens and their role in antigenicity in rat tumor cells.
    Moriuchi T
    Hokkaido Igaku Zasshi; 1979 Sep; 54(5):487-99. PubMed ID: 93561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo elimination by specific effector cells of an established syngeneic rat moloney virus-induced sarcoma.
    Fernandez-Cruz E; Halliburton B; Feldman JD
    J Immunol; 1979 Oct; 123(4):1772-7. PubMed ID: 158055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of SV40 tumor-mediated suppression of spleen cell cytotoxicity by antibody.
    Prather SO; Lausch RN
    J Immunol; 1977 Jan; 118(1):203-10. PubMed ID: 187698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of cytotoxic lymphocytes by SV40-induced antigens.
    Chang C; Chang R; Mora PT; Hu CP
    J Immunol; 1982 May; 128(5):2160-3. PubMed ID: 6278025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Passive transfer of systemic tumor immunity with cells generated in vitro by a secondary immune response to a syngeneic rat gross virus-induced lymphoma.
    Bernstein ID
    J Immunol; 1977 Jan; 118(1):122-8. PubMed ID: 830744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo antigenic modification of tumor cells. III. Metastatic thymic lymphoma specifically infected by thymotropic retrovirus.
    Iglehart JD; Weinhold KJ; Huper G; Thiel K; Bolognesi DP
    J Natl Cancer Inst; 1981 Jul; 67(1):123-30. PubMed ID: 6265678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of immunity induced by neuraminidase-treated lymphosarcoma cells in C3H (MTV+) and C3H (MTV-) mice.
    Bekesi JG; Roboz JP; Holland JF
    Isr J Med Sci; 1976; 12(4-5):288-303. PubMed ID: 181351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-T-cell-mediated cytotoxicity in mice with tumors induced by Moloney murine sarcoma virus (M-MuSV). II. Granulocyte-mediatd cytotoxicity against autochthonous target cells isolated from M-MuSV-induced tumors.
    Becker S; Haskill S
    J Natl Cancer Inst; 1980 Aug; 65(2):469-75. PubMed ID: 6249952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.